Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
-$0.13 today
- Market cap
- $432.04M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
Volume 0.09M
Average 0.10M
SI Operating Cash Flow
Cash generated by the company's core business operations during the period.
Shoulder Innovations, Inc.NYSE: SI
Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Operating cash flow grows 90.8% year over year
Q1 FY2026 operating cash flow of $12.36M (cash outflow) rose 90.8% year over year. Sequentially, it rose 40.7% from the prior quarter.
Context
- Operating cash flow amounted to 60.5% of revenue in FY2025, up 15.7 pp from a year earlier.
- Operating cash flow grew in size in 2 of the last 2 fiscal years.
- FY2025 was the largest annual figure in the 3 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (28.61M) USD
- Year-over-year change
- -102.3%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (28.61M) | -102.3% |
| FY2024 | 2024-12-31 | (14.14M) | -7.6% |
| FY2023 | 2023-12-31 | (13.14M) | — |
Operating Cash Flow vs competitors
How SI compares with its peers on the latest reported figures
- SI's LTM Mar 2026 operating cash flow of $34.49M is the 5th largest of the 11 companies compared; the peer median is $32.47M.
- Operating cash flow amounts to 64.0% of revenue for SI, versus a peer median of 13.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $61.65M | +126.0% | +72.6% | — | |
| LTM Mar 2026 | $49.86M | -12.2% | +3.4% | — | |
| LTM Dec 2025 | $43.17M | +18.0% | -2.0% | 331.6% | |
| LTM Mar 2026 | $39.75M | -29.3% | -21.3% | 55.9% | |
| LTM Mar 2026 | $34.49M | — | — | 64.0% | |
| LTM Mar 2026 | $33.51M | -65.1% | -31.8% | 28.5% | |
EPRXEupraxia Pharmaceuticals Inc. | LTM Mar 2026 | $31.43M | +25.2% | +26.3% | — |
| FY2025 | $10.42M | -43.8% | -32.7% | 9.7% | |
| LTM Mar 2026 | $7.84M | -85.9% | -39.0% | 11.3% | |
| LTM Mar 2026 | $5.79M | +3674.1% | — | 13.1% | |
| LTM Mar 2026 | $1.11M | -81.9% | -33.1% | 0.3% | |
| Peer median (excluding SI) | $32.47M | -20.8% | -21.3% | 13.1% | |
Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Net Income | (12.66M) | (15.62M) | (40.36M) |
| Depreciation & Amortization | 1.64M | 2.2M | 3.21M |
| Deferred Income Tax | 0 | 0 | 0 |
| Stock-Based Compensation | 451K | 754K | 996K |
| Change in Working Capital | (4.77M) | (1.04M) | 0 |
| Accounts Receivables | (2.69M) | (575K) | (3.3M) |
| Inventory | (2.41M) | (4.03M) | (7.64M) |
| Accounts Payables | (737K) | 3.12M | 3.37M |
| Other Working Capital | 1.08M | 446K | 0 |
| Other Non-Cash Items | 2.18M | (437K) | 7.54M |
| Operating Cash Flow | (13.14M) | (14.14M) | (28.61M) |
| Capital Expenditures | (2.75M) | (4.02M) | (7.41M) |
| Acquisitions (Net) | 0 | 0 | 0 |
| Purchases of Investments | (29.25M) | (5.28M) | (119.49M) |
| Sales of Investments | 3.03M | 23.26M | 31.3M |
| Other Investing Activities | 0 | 0 | 0 |
| Investing Cash Flow | (28.97M) | 13.96M | (95.6M) |
| Debt Repayment | 10M | 0 | 0 |
| Common Stock Issued | 34.88M | 66K | 39.51M |
| Common Stock Repurchased | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 |
| Other Financing Activities | (149K) | 66K | 144.96M |
| Financing Cash Flow | 44.73M | 66K | 144.96M |
| Effect of Forex Changes | 0 | 0 | 0 |
| Net Change in Cash | 2.61M | (113K) | 20.75M |
| Free Cash Flow | (15.89M) | (18.16M) | (36.02M) |
Shoulder Innovations, Inc.
NYSE:SI
Intrinsic Alpha fair value
Locked
Current Price
$20.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.